Circadian change of serum concentration of small dense LDL-cholesterol in type 2 diabetic patients. 2010

Satoshi Hirayama, and Satoshi Soda, and Yasuki Ito, and Hiroshi Matsui, and Tsuyoshi Ueno, and Yoshifumi Fukushima, and Hirotoshi Ohmura, and Osamu Hanyu, and Yoshifusa Aizawa, and Takashi Miida
Department of Clinical Laboratory Medicine, Juntendo University School of Medicine, Tokyo, Japan. sthiraya@juntendo.ac.jp

BACKGROUND Type 2 diabetic patients have a higher risk of atherosclerosis than non-diabetic subjects. This difference may be attributable to increased levels of small dense low-density lipoprotein-cholesterol (sLDL-C) in diabetic patients. As the sLDL-C concentration is elevated in hypertriglyceridemia, which is exaggerated postprandially, we examined whether the sLDL-C level increases postprandially in type 2 diabetes. METHODS We obtained 7 blood samples (30min before and 2h after each meal, and at midnight) from 15 patients with diabetes and ten normal controls. Following the precipitation of very low-density lipoprotein and large buoyant LDL (bLDL) with heparin-Mg(2+), the sLDL-C concentration was determined as the cholesterol concentration by a homogeneous assay. RESULTS The fasting sLDL-C concentration was 60.3% higher in the diabetic patients than in the controls (1.01+/-0.21 vs. 0.63+/-0.21mmol/l, p<0.001). The sLDL-C concentrations in both groups were highest in the fasting state, decreased after breakfast, and remained low until midnight. The maximal reduction in the absolute sLDL-C concentration was 56.5% greater in the diabetic patients than in the controls (0.36+/-0.13 vs. 0.23+/-0.16mmol/l, p<0.05). Thus, the sLDL-C/bLDL-cholesterol (bLDL-C) ratio was reduced with increases in bLDL-C. CONCLUSIONS The sLDL-C concentration decreases postprandially in diabetes. This absolute reduction in sLDL-C may contribute to an acceleration of atherosclerosis in diabetic patients.

UI MeSH Term Description Entries
D008076 Cholesterol, HDL Cholesterol which is contained in or bound to high-density lipoproteins (HDL), including CHOLESTEROL ESTERS and free cholesterol. High Density Lipoprotein Cholesterol,Cholesterol, HDL2,Cholesterol, HDL3,HDL Cholesterol,HDL(2) Cholesterol,HDL(3) Cholesterol,HDL2 Cholesterol,HDL3 Cholesterol,alpha-Lipoprotein Cholesterol,Cholesterol, alpha-Lipoprotein,alpha Lipoprotein Cholesterol
D008078 Cholesterol, LDL Cholesterol which is contained in or bound to low density lipoproteins (LDL), including CHOLESTEROL ESTERS and free cholesterol. LDL Cholesterol,Cholesteryl Linoleate, LDL,LDL Cholesteryl Linoleate,Low Density Lipoprotein Cholesterol,beta-Lipoprotein Cholesterol,Cholesterol, beta-Lipoprotein,beta Lipoprotein Cholesterol
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002940 Circadian Rhythm The regular recurrence, in cycles of about 24 hours, of biological processes or activities, such as sensitivity to drugs or environmental and physiological stimuli. Diurnal Rhythm,Nyctohemeral Rhythm,Twenty-Four Hour Rhythm,Nycthemeral Rhythm,Circadian Rhythms,Diurnal Rhythms,Nycthemeral Rhythms,Nyctohemeral Rhythms,Rhythm, Circadian,Rhythm, Diurnal,Rhythm, Nycthemeral,Rhythm, Nyctohemeral,Rhythm, Twenty-Four Hour,Rhythms, Circadian,Rhythms, Diurnal,Rhythms, Nycthemeral,Rhythms, Nyctohemeral,Rhythms, Twenty-Four Hour,Twenty Four Hour Rhythm,Twenty-Four Hour Rhythms
D003924 Diabetes Mellitus, Type 2 A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. Diabetes Mellitus, Adult-Onset,Diabetes Mellitus, Ketosis-Resistant,Diabetes Mellitus, Maturity-Onset,Diabetes Mellitus, Non-Insulin-Dependent,Diabetes Mellitus, Slow-Onset,Diabetes Mellitus, Stable,MODY,Maturity-Onset Diabetes Mellitus,NIDDM,Diabetes Mellitus, Non Insulin Dependent,Diabetes Mellitus, Noninsulin Dependent,Diabetes Mellitus, Noninsulin-Dependent,Diabetes Mellitus, Type II,Maturity-Onset Diabetes,Noninsulin-Dependent Diabetes Mellitus,Type 2 Diabetes,Type 2 Diabetes Mellitus,Adult-Onset Diabetes Mellitus,Diabetes Mellitus, Adult Onset,Diabetes Mellitus, Ketosis Resistant,Diabetes Mellitus, Maturity Onset,Diabetes Mellitus, Slow Onset,Diabetes, Maturity-Onset,Diabetes, Type 2,Ketosis-Resistant Diabetes Mellitus,Maturity Onset Diabetes,Maturity Onset Diabetes Mellitus,Non-Insulin-Dependent Diabetes Mellitus,Noninsulin Dependent Diabetes Mellitus,Slow-Onset Diabetes Mellitus,Stable Diabetes Mellitus
D005215 Fasting Abstaining from FOOD. Hunger Strike,Hunger Strikes,Strike, Hunger,Strikes, Hunger
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Satoshi Hirayama, and Satoshi Soda, and Yasuki Ito, and Hiroshi Matsui, and Tsuyoshi Ueno, and Yoshifumi Fukushima, and Hirotoshi Ohmura, and Osamu Hanyu, and Yoshifusa Aizawa, and Takashi Miida
June 2006, Rinsho byori. The Japanese journal of clinical pathology,
Satoshi Hirayama, and Satoshi Soda, and Yasuki Ito, and Hiroshi Matsui, and Tsuyoshi Ueno, and Yoshifumi Fukushima, and Hirotoshi Ohmura, and Osamu Hanyu, and Yoshifusa Aizawa, and Takashi Miida
February 2007, Clinica chimica acta; international journal of clinical chemistry,
Satoshi Hirayama, and Satoshi Soda, and Yasuki Ito, and Hiroshi Matsui, and Tsuyoshi Ueno, and Yoshifumi Fukushima, and Hirotoshi Ohmura, and Osamu Hanyu, and Yoshifusa Aizawa, and Takashi Miida
August 2007, Rinsho byori. The Japanese journal of clinical pathology,
Satoshi Hirayama, and Satoshi Soda, and Yasuki Ito, and Hiroshi Matsui, and Tsuyoshi Ueno, and Yoshifumi Fukushima, and Hirotoshi Ohmura, and Osamu Hanyu, and Yoshifusa Aizawa, and Takashi Miida
October 2011, Diabetes & metabolism journal,
Satoshi Hirayama, and Satoshi Soda, and Yasuki Ito, and Hiroshi Matsui, and Tsuyoshi Ueno, and Yoshifumi Fukushima, and Hirotoshi Ohmura, and Osamu Hanyu, and Yoshifusa Aizawa, and Takashi Miida
May 2022, Journal of atherosclerosis and thrombosis,
Satoshi Hirayama, and Satoshi Soda, and Yasuki Ito, and Hiroshi Matsui, and Tsuyoshi Ueno, and Yoshifumi Fukushima, and Hirotoshi Ohmura, and Osamu Hanyu, and Yoshifusa Aizawa, and Takashi Miida
December 2009, Atherosclerosis,
Satoshi Hirayama, and Satoshi Soda, and Yasuki Ito, and Hiroshi Matsui, and Tsuyoshi Ueno, and Yoshifumi Fukushima, and Hirotoshi Ohmura, and Osamu Hanyu, and Yoshifusa Aizawa, and Takashi Miida
May 2007, Rinsho byori. The Japanese journal of clinical pathology,
Satoshi Hirayama, and Satoshi Soda, and Yasuki Ito, and Hiroshi Matsui, and Tsuyoshi Ueno, and Yoshifumi Fukushima, and Hirotoshi Ohmura, and Osamu Hanyu, and Yoshifusa Aizawa, and Takashi Miida
June 2007, Journal of atherosclerosis and thrombosis,
Satoshi Hirayama, and Satoshi Soda, and Yasuki Ito, and Hiroshi Matsui, and Tsuyoshi Ueno, and Yoshifumi Fukushima, and Hirotoshi Ohmura, and Osamu Hanyu, and Yoshifusa Aizawa, and Takashi Miida
January 2012, British journal of biomedical science,
Satoshi Hirayama, and Satoshi Soda, and Yasuki Ito, and Hiroshi Matsui, and Tsuyoshi Ueno, and Yoshifumi Fukushima, and Hirotoshi Ohmura, and Osamu Hanyu, and Yoshifusa Aizawa, and Takashi Miida
July 2023, Diabetology international,
Copied contents to your clipboard!